We are live on
!
Find out more
AR
Apeiron RIA Portfolio holdings
AUM
$390M
1-Year Est. Return
22.97%
This Fund
S&P 500
This Quarter
Est. Return
+1.75%
1 Year Est. Return
+22.97%
3 Year Est. Return
+63.71%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$326M
AUM Growth
-$18.9M
(-5.5%)
Cap. Flow
-$23.2M
Cap. Flow
% of AUM
-7.1%
Top 10 Holdings %
Top 10 Hldgs %
36.92%
Holding
214
New
6
Increased
100
Reduced
71
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P 500 Growth ETF
IVW
|
+$6.44M |
| 2 |
BlackRock US Equity Factor Rotation ETF
DYNF
|
+$2.84M |
| 3 |
iShares MSCI EAFE Growth ETF
EFG
|
+$1.81M |
| 4 |
JPMorgan US Value Factor ETF
JVAL
|
+$909K |
| 5 |
iShares MSCI Emerging Markets ex China ETF
EMXC
|
+$880K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$14.6M |
| 2 |
Abbott
ABT
|
+$9.16M |
| 3 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$5.62M |
| 4 |
iShares MSCI EAFE Value ETF
EFV
|
+$3.17M |
| 5 |
iShares ESG Aware MSCI USA ETF
ESGU
|
+$2.18M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.7% |
| 2 | Healthcare | 1.91% |
| 3 | Consumer Staples | 1.69% |
| 4 | Consumer Discretionary | 1.61% |
| 5 | Financials | 1.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
iShares Core S&P Small-Cap ETF
IJR
$109B
| $206K | 0.06% |
1,933
+11
| +0.6% | +$1.18K |
|
202
Equifax
EFX
$20.3B
| $206K | 0.06% |
850
| – | – |
|
203
Eli Lilly
LLY
$1.07T
| $200K | 0.06% |
+221
| New | +$177K |
|
204
Nuveen AMT-Free Quality Municipal Income Fund
NEA
$3.36B
| $170K | 0.05% |
14,808
| – | – |
|
|
205
AbbVie
ABBV
$458B
| – | – |
-80,008
| Closed | -$14.6M |
|
|
206
Abbott
ABT
$180B
| – | – |
-80,614
| Closed | -$9.16M |
|
207
JPMorgan BetaBuilders USD High Yield Corporate Bond ETF
BBHY
$614M
| – | – |
-40,500
| Closed | -$1.87M |
|
208
Salesforce
CRM
$134B
| – | – |
-702
| Closed | -$211K |
|
209
First Trust Financials AlphaDEX Fund
FXO
$1.12B
| – | – |
-6,223
| Closed | -$296K |
|
210
First Trust Materials AlphaDEX Fund
FXZ
$378M
| – | – |
-3,233
| Closed | -$231K |
|
211
MetLife
MET
$61B
| – | – |
-2,779
| Closed | -$206K |
|
212
Prologis
PLD
$138B
| – | – |
-1,618
| Closed | -$211K |
|
213
iShares Treasury Floating Rate Bond ETF
TFLO
$6.56B
| – | – |
-21,918
| Closed | -$1.11M |
|
Similar funds
HP
WCM
CFA
SA
AIM
PG
S
SI
Apeiron RIA's Q2 2024 Portfolio in Review
As of Q2 2024, Apeiron RIA held 214 positions worth $326M, down 5.5% from $345M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Apeiron RIA withdrew a net $23.2M in Q2 2024, closing 9 positions and reducing 71 holdings. Its most notable exit was AbbVie, an estimated $14.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 4.7% of assets, up from 4% a quarter earlier, followed by Healthcare and Consumer Staples.
Against the trend, Apeiron RIA opened a new position in iShares Bitcoin Trust worth $745K.
- Apeiron RIA's largest Q2 2024 buy was iShares Bitcoin Trust: 21,824 shares worth $745K.
- Apeiron RIA added most to iShares S&P 500 Growth ETF in Q2 2024, an estimated $6.44M increase.
- Apeiron RIA's biggest Q2 2024 reduction was State Street SPDR Portfolio S&P 500 ETF, cutting an estimated $5.62M.
- Apeiron RIA fully exited AbbVie in Q2 2024, selling an estimated $14.6M.
- Apeiron RIA's ten largest holdings make up 37% of its $326M portfolio in Q2 2024.
- Apeiron RIA opened 6 new positions and closed 9 in Q2 2024.
- Apeiron RIA's portfolio value fell 5.5% quarter-over-quarter to $326M.
Based on Apeiron RIA's 13F filing for Q2 2024, filed 16 Jul 2024.